1. ACTR-06. CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM: HALF-WAY REPORT. (11th November 2019) Authors: Chen, Zhong-ping; Guo, Chengcheng; Yang, Qun-ying; Li, Jia-wei; Wu, Shao-xiong; Bacha, Jeffrey; Johnson, Gregory; Langlands, John; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Lopez, Lorena; Brown, Dennis Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. (11th November 2019) Authors: O'Brien, Barbara; Penas-Prado, Marta; Kamiya, Carolos; Pei Weathers, Shiao-; Yung, Alfred; Loghin, Monica; Harrison, Rebecca; Bacha, Jeffrey; Brown, Dennis; Johnson, Gregory; Langlands, John; Schwartz, Richard; Kanekal, Sarath; Lopez, Lorena; deGroot, John Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-71. PHASE 1/2 STUDY OF DIANHYDROGALACTITOL (VAL-083) WITH RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA. (5th November 2018) Authors: Chen, Zhong-ping; Guo, Chengcheng; Bacha, Jeffrey; Steino, Anne; Langlands, John; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Lopez, Lorena; Brown, Dennis Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTNI-21. PHASE 2 STUDY OF VAL-083 AND RADIOTHERAPY IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM. (12th November 2021) Authors: Chen, Zhong-ping; Guo, Cheng-Cheng; Qun-ying, Yang; Li, Jia-Wei; Wu, Shao-xiong; Bacha, Jeffrey; Johnson, Gregory; Langlands, John; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Steino, Anne; Brown, Dennis Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTNI-26. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. (12th November 2021) Authors: O'Brien, Barbara; Penas-Prado, Marta; Kamiya-Matsuoka, Carlos; Weathers, Shiao-Pei; Yung, W K Alfred; Loghin, Monica; Harrison, Rebecca; Majd, Nazanin; Knight, Stephanie; Bacha, Jeffrey; Brown, Dennis; Johnson, Gregory; Langlands, John; Schwartz, Richard; Kanekal, Sarath; Steino, Anne; Lopez, Lor... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTNI-72. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. (9th November 2020) Authors: O'Brien, Barbara; Penas-Prado, Marta; Kamiya-Matsuoka, Carlos; Weathers, Shiao-Pei; Yung, W K Alfred; Loghin, Monica; Harrison, Rebecca; Majd, Nazanin; Bacha, Jeffrey; Brown, Dennis; Johnson, Greg; Langlands, John; Schwartz, Richard; Kanekal, Sarath; Steino, Anne; Lopez, Lorena; de Groot, John Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTNI-76. PHASE 2 CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM. (9th November 2020) Authors: Chen, Zhong-ping; Guo, Cheng-Cheng; Yang, Qun-ying; Wu, Shao-xiong; Li, Jia-Wei; Bacha, Jeffrey; Johnson, Greg; Langlands, John; Schwartz, Richard; Kwan, Claire; Kanekal, Sarath; Steino, Anne; Lopez, Lorena; Brown, Dennis Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DDDR-34. RECURRENT RELA FUSION-POSITIVE EPENDYMOMA TREATED WITH VAL-083 UNDER EXPANDED ACCESS: A CASE REPORT. (14th November 2022) Authors: Kamiya-Matsuoka, Carlos; Knight, Stephanie; Langlands, John; Brown, Dennis; Puduvalli, Vinay Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DDDR-36. VAL-083 IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED UNDER EXPANDED ACCESS PROGRAM. (14th November 2022) Authors: Kamiya-Matsuoka, Carlos; Majd, Nazanin; Harrison, Rebecca; Knight, Stephanie; Langlands, John; Brown, Dennis; Puduvalli, Vinay Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SYST-05. PHASE 2 STUDY OF VAL-083 AND RADIOTHERAPY IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM. (21st September 2021) Authors: Chen, Zhong-ping; Guo, Cheng-cheng; Yang, Qun-ying; Li, Jia-wei; Wu, Shao-xiong; Bacha, Jeffrey; Johnson, Greg; Langlands, John; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Brown, Dennis Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗